KAYE RANDALL (CMO) exercised options at LONGBOARD PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/19/2024ACC: 0000950170-24-128962
Officer· CMO
Since Mar 2022
0.00
Net shares
Net seller
$183.3K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
30.55K acquired · 30.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30.55K
Price / share
$6.00
Trade value
$183.32K
% of position
170.5%
11/19/2024
17.92K→48.47K
Total
Net shares
+30.55K
Net value
$183.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/19/2024 | M · Option Exercise | +30.55K | $6.00 | $183.32K | 170.5% | 17.92K | 48.47K |
| Total | +30.55K | $183.32K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30.55K shares
Shares
−30.55K
Strike price
6
Held after
175.95K
Exercisable
—
11/19/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30.55K shares | 11/19/2024 | M · Option Exercise | −30.55K | 6 | — | 175.95K |